Facebook
Twitter
Youtube
LOGIN
Ocular Research Journal
Home
About The Journal
Editorial Team
Policies
Advertising Policy
Aims & Scope
Archiving
Article Processing Charges
Article Submission Charges
Brief Overview
Creative Commons Licensing Information
Crossmark Policy
Ethics in Journal Publishing
Indexing & Abstracting
Open Access Policy
Peer Review Process
Permissions/Conflict of Interest Policy/Copyrights
Plagiarism Note
Publication Frequency
Section Policies
Waiver Policy
Submissions
Author Guidelines
Others
Ahead of Print
Current Issue
Archives
Contact Us
Menu
Home
About The Journal
Editorial Team
Policies
Advertising Policy
Aims & Scope
Archiving
Article Processing Charges
Article Submission Charges
Brief Overview
Creative Commons Licensing Information
Crossmark Policy
Ethics in Journal Publishing
Indexing & Abstracting
Open Access Policy
Peer Review Process
Permissions/Conflict of Interest Policy/Copyrights
Plagiarism Note
Publication Frequency
Section Policies
Waiver Policy
Submissions
Author Guidelines
Others
Ahead of Print
Current Issue
Archives
Contact Us
Sustained-release intravitreal dexamethasone(Ozurdex®) implant as a surgical adjuvant in high-risk proliferative vitreoretinopathy
Original Article
